Ignite Creation Date:
2025-12-25 @ 2:34 AM
Ignite Modification Date:
2026-05-12 @ 9:43 PM
Study NCT ID:
NCT04209634
Status:
COMPLETED
Last Update Posted:
2025-08-29
First Post:
2019-12-20
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Open-Label Efficacy and Safety Study of Pozelimab in Patients With CD55-Deficient Protein-Losing Enteropathy (CHAPLE Disease)
Sponsor:
Regeneron Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
R3918-PLE-1878
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None